Arrowhead Pharmaceuticals (STU:HDP1) Change In Payables And Accrued Expense : €24.51 Mil (TTM As of Sep. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Arrowhead Pharmaceuticals Change In Payables And Accrued Expense?

Arrowhead Pharmaceuticals's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was €9.65 Mil. It means Arrowhead Pharmaceuticals's Accounts Payable & Accrued Expense increased by €9.65 Mil from Jun. 2024 to Sep. 2024 .

Arrowhead Pharmaceuticals's Change In Payables And Accrued Expense for the fiscal year that ended in Sep. 2024 was €23.95 Mil. It means Arrowhead Pharmaceuticals's Accounts Payable & Accrued Expense increased by €23.95 Mil from Sep. 2023 to Sep. 2024 .

Arrowhead Pharmaceuticals Change In Payables And Accrued Expense Historical Data

The historical data trend for Arrowhead Pharmaceuticals's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arrowhead Pharmaceuticals Change In Payables And Accrued Expense Chart

Arrowhead Pharmaceuticals Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.99

10.33

11.27

16.90

23.95

Arrowhead Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															42.27	-11.05	3.35	22.56	9.65

Arrowhead Pharmaceuticals Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €24.51 Mil.

Arrowhead Pharmaceuticals Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Arrowhead Pharmaceuticals's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Arrowhead Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arrowhead Pharmaceuticals Inc (STU:HDP1) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

ARWR:USA ARWR:Mexico 0HI3:UK HDP1:Germany

Address

177 E. Colorado Boulevard, Suite 700, Pasadena, CA, USA, 91105

Website

https://www.arrowheadpharma.com

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Arrowhead Pharmaceuticals Headlines

No Headlines